Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic.

Bookmark this %label%

Rheumatology teams care for patients with diverse, systemic autoimmune diseases who are often immunosuppressed and at high risk of infections. The current COVID-19 pandemic has presented particular challenges in caring […]

» Read more

Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management.

Bookmark this %label%

Due to the frequent presence of interstitial lung disease and widespread use of immunosuppressive treatment, systemic sclerosis (SSc) patients may be considered at risk for a more severe disease course […]

» Read more

Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus.

Bookmark this %label%

Systemic lupus erythematosus is a chronic remitting-relapsing autoimmune disease that affects multiple organ systems. In this article we discuss aspects in the management of lupus patients that are particularly relevant […]

» Read more

American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID-19 Pandemic.

Bookmark this %label%

To provide guidance to rheumatology providers on the management of adult rheumatic disease patients in the context of the COVID-19 pandemic.A task force, including 10 rheumatologists and 4 infectious diseases […]

» Read more

[Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic].

Bookmark this %label%

In the current SARS-CoV-2 pandemic there are many questions regarding the safe treatment of patients with inflammatory rheumatic diseases. Many of these questions cannot yet be answered on an evidence-based […]

» Read more

The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: ‘Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India’ by Gupta et al and ‘Antirheumatic agents in covid-19: is IL-6 the right target?’ by Capeechi et al.

Bookmark this %label%

Click here to read the full article @ Annals of the rheumatic diseases

» Read more

Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis.

Bookmark this %label%

The outbreak of COVID-19 in December 2019 in China has very quickly become a global health emergency with almost two million of infected patients worldwide.[1] Along with the spread of […]

» Read more

The Question of Whether to Remain on Therapy for Chronic Rheumatic Diseases in the Setting of the Covid-19 Pandemic.

Bookmark this %label%

We appreciate our Italian colleagues’ interest in our editorial denoting the rheumatologist’s role in helping to diagnose and treat cytokine storm syndrome (CSS) in the setting of the Covid-19 panemic […]

» Read more

COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country.

Bookmark this %label%

On March 11th, 2020 the World Health Organization declared COVID-19 a global pandemic. The infection, transmitted by 2019 novel coronavirus (2019-nCov), was first discovered in December 2019, in Wuhan, Hubei […]

» Read more

Stand Together and Deliver: Challenges and Opportunities for Rheumatology Education During the COVID19 Pandemic.

Bookmark this %label%

In a matter of weeks, the COVID19 crisis has totally upended clinical medicine and the practice of rheumatology. Our old ways of seeing patients in person, precepting fellows in clinic […]

» Read more